导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 10.06% | 712/4773 |
| 近一周 | -3.07% | 3619/5462 |
| 近一月 | -7.76% | 3961/5421 |
| 近一季 | -8.07% | 2668/5209 |
| 近半年 | 8.76% | 565/4920 |
| 近一年 | 12.28% | 855/4366 |
| 近两年 | 121.69% | 389/2954 |
| 近三年 | 77.52% | 227/2253 |
| 成立以来 | 96.18% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.33% 4101/4961 |
43.28% 707/5312 |
- - |
- - |
| 2025 | 38.94% 853/4813 |
1.43% 1623/3635 |
1.19% 2424/4076 |
41.37% 730/4524 |
-4.25% 3426/4813 |
| 2024 | 18.67% 584/3463 |
-5.09% 1835/2808 |
-2.75% 1244/3014 |
16.69% 1381/3129 |
10.18% 286/3463 |
| 2023 | 8.65% 125/2656 |
28.65% 77/2280 |
-1.43% 485/2385 |
-11.19% 2046/2515 |
-3.53% 715/2655 |
| 2022 | -32.21% 1673/2207 |
-24.13% 1756/1919 |
0.89% 1520/2016 |
-17.21% 1561/2113 |
6.98% 336/2208 |
| 2021 | 7.44% 496/1822 |
-8.16% 1078/1255 |
17.55% 186/1330 |
-7.46% 1054/1466 |
7.55% 179/1822 |
| 2020 | 44.10% 234/1250 |
3.01% 128/1022 |
30.93% 43/1060 |
1.37% 1019/1152 |
- - |
| 2019 | 53.48% 81/1092 |
30.93% 216/748 |
-5.07% 447/797 |
12.16% 33/844 |
10.10% 157/912 |
| 2018 | -33.31% 549/834 |
- - |
- - |
- - |
-13.97% 564/691 |
| 2017 | 3.13% 431/714 |
- - |
- - |
- - |
- - |
| 2016 | -28.26% 495/605 |
- - |
- - |
- - |
- - |
| 2015 | 27.42% 83/575 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 富国中证移动互联网指数(LOF)A VS. 长安沪深300非周期A(740101) |